Blog Profile / EurekAlert: Cancer

Filed Under:Diseases & Conditions / Cancer
Posts on Regator:1521
Posts / Week:21.2
Archived Since:September 5, 2016

Blog Post Archive

MIT Portugal is developing a Compression sleeve for breast cancer patients

(MIT Portugal Program) The project developed by the MIT Portugal PhD Student at the University of Minho Carlos Gonçalves, was considered the most innovative of the 9 projects incubated during 10 weeks by Startup Nano, a pioneer incubation...Show More Summary

CancerSEEK: Generalized screening for multiple cancer types

(American Association for the Advancement of Science) Researchers have developed a noninvasive blood test based on combined analysis of DNA and proteins that may allow earlier detection of eight common cancer types. In more than 1,000 patients, their method, dubbed CancerSEEK, detected cancer with a sensitivity of 69 to 98 percent (depending on cancer type).

Scientists identify potential target genes to halt progression of thyroid cancer

(Fundação de Amparo à Pesquisa do Estado de São Paulo) Research shows that expression of 52 microRNAs falls as the disease becomes more aggressive. Restoring levels of these molecules in the tumor could be a novel therapeutic strate...

New drug combination helps kickstart the immune system to fight back against cancer

(King's College London) Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer. The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialed as a treatment for neonatal jaundice, that together help kick start the body's natural defenses.

Presurgical targeted therapy delays relapse of high-risk stage 3 melanoma

(University of Texas M. D. Anderson Cancer Center) A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at The University of Texas MD Anderson Cancer Center report in Lancet Oncology. Show More Summary

Patients with blood cancer precursor at risk of developing cancer even after 30 years

(Mayo Clinic) Patients with monoclonal gammopathy of undetermined significance are at risk of progressing to multiple myeloma or a related cancer -- even after 30 years of stability. These are the findings of a study by Mayo Clinic researchers published in the Wednesday, Jan. 17, issue of the New England Journal of Medicine.

Mammogram rates increase after ACA eliminates co-payments

(Brown University) A new study finds that screening mammogram rates increased after the Affordable Care Act eliminated out-of-pocket costs.

Novel precision medicine trial for metastatic pancreatic cancer

(Columbia University Medical Center) The Lustgarten Foundation has awarded Columbia University's Herbert Irving Comprehensive Cancer Center (HICCC) a three-year grant, as part of its Translational Clinical Program, to test a new precision medicine approach to the treatment of metastatic pancreatic cancer.

Review examines the pros and cons of surgery to reduce the risk of cancer

(Wiley) Genetic testing is commonplace for many inheritable cancer syndromes, and with that comes the knowledge of being a gene carrier for some patients. Many guidelines recommend that gene carriers take certain steps, such as surgery, to reduce their risk of developing cancer. Show More Summary

New research could significantly accelerate drug discovery

(University of Maryland School of Medicine) Many drugs work by inhibiting protein enzymes associated with a particular disease. Unfortunately, the same drugs can inhibit protein enzymes unrelated to the disease, resulting in harmful side effects. Show More Summary

Patient-derived organoids may help personalize the treatment of gastrointestinal cancers

(Wiley) A new BJS (British Journal of Surgery) review highlights the potential of 3-D organoid models derived from patient cells to help personalize therapy for individuals with gastrointestinal cancers.

Who might benefit from immunotherapy? New study suggests possible marker

(Michigan Medicine - University of Michigan) New research finds that PDL-1 expressed in antigen presenting cells -- macrophages and dendritic cells found in the tumor microenvironment and in the nearby lymph nodes -- is a better indicator than PDL-1 in the tumor of who will respond to immunotherapy drugs.

Bladder Cancer named the official journal of the Bladder Cancer Advocacy Network

(IOS Press) IOS Press, an international scientific, technical and medical publisher, and the Bladder Cancer Advocacy Network (BCAN), are pleased to announce that the journal Bladder Cancer is now the official journal of BCAN.

IDIBELL researchers successfully test a new combination therapy in sarcomas

(IDIBELL-Bellvitge Biomedical Research Institute) Researchers of the Sarcoma group of the Oncobell program -- Bellvitge Biomedical Research Institute (IDIBELL) have successfully tested a new combined therapy for the treatment of this rare, aggressive tumor type, which affects children and adults.

Scientists identify genes implicated in the high regenerative capacity of embryos and ESCs

(Biogerontology Research Foundation) Researchers at Insilico Medicine, AgeX Therapeutics and the Biogerontology Research Foundation have published a landmark study titled 'Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells' in the journal Oncotarget.

More evidence of link between severe gum disease and cancer risk

(Tufts University, Health Sciences Campus) A new study adds to accumulating research that gum disease is associated with some cancer risk. It reports a 24 percent increase in the risk of cancer among participants with severe gum disease. The highest risk was observed in cases of lung cancer, followed by colorectal cancer.

From a novel support group to a book, learning from seven widowed fathers

(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center's Donald Rosenstein, MD, and Justin Yopp, PhD, have published 'The Group: Seven Widowed Fathers Reimagine Life,' which tells the story of personal...Show More Summary

Normal tissue BRCA1 methylation associated with risk for high-grade ovarian cancer

(American College of Physicians) Normal tissue BRCA1 methylation is associated with risk for high-grade ovarian cancer and may occur as a prenatal event. These findings are published in Annals of Internal Medicine.

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

(Beth Israel Deaconess Medical Center) The field of immunotherapy -- the harnessing of patients' own immune systems to fend off cancer -- is revolutionizing cancer treatment today. However, clinical trials often show marked improvements...Show More Summary

Researchers demonstrate RAS dimers are essential for cancer

(UT Southwestern Medical Center) Researchers at UT Southwestern's Simmons Cancer Center have shown that RAS molecules act in pairs, known as dimers, to cause cancer, findings that could help guide them to a treatment.

Copyright © 2015 Regator, LLC